Neurogene Inc (NGNE) Hedge Fund Ownership (Q2 2026)

Q: Is it too late to buy Neurogene Inc (NGNE) following the 2026 Q2 hedge fund 13F filings?

As of today, NGNE has moved +6.9% since the 2026 Q2 13F filing date (August 14, 2026), compared to +4.3% for the XLV sector ETF — an outperformance of +2.6%. Since the quarter end (June 30, 2026), NGNE gained +22.8% vs +10.1% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Neurogene Inc (NGNE)

111 + Investors. Track Smart Money conviction in NGNE. See who's accumulating, reducing, or initiating positions.

Smart Money Signals — NGNE

Based on 112 hedge funds · latest filing: 2026 Q2 · updated quarterly

📈

Buying streak — 4 quarters in a row

last 6Q

For 4 consecutive quarters, more hedge funds added NGNE than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

🏔️

At the ownership peak (100% of max)

100% of all-time peak

112 hedge funds hold NGNE right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.

🚀

Fast accumulation — +35% more funds vs a year ago

fund count last 6Q

+29 new funds entered over the past year (+35% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.

🟢

More buyers than sellers — 62% buying

63 buying39 selling

Last quarter: 63 funds were net buyers (23 opened a brand new position + 40 added to an existing one). Only 39 were sellers (31 trimmed + 8 sold completely). A clear majority buying is a strong confirmation signal.

➡️

Steady new buyers — ~23 new funds per quarter

new funds entering per quarter

Funds opening this position for the first time: 15 → 16 → 18 → 23. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.

📌

Mixed — 36% long-term, 29% new

■ 36% conviction (2yr+) ■ 36% medium ■ 29% new

Of the 112 current holders: 40 (36%) held >2 years, 40 held 1–2 years, and 32 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.

💰

Value +59% but shares only +2% — price-driven

Value

+59%

+1%

Last quarter: the total dollar value of institutional holdings rose +59%, but actual share count only changed +2%. The gap is explained by the stock's price rising — not new buying. Strong value growth with weak share growth means the rally is price momentum, not fresh institutional demand.

📈

Growing discovery — still being found

11 → 15 → 16 → 18 → 23 new funds/Q

New funds entering each quarter: 15 → 16 → 18 → 23. A growing number of institutions are discovering NGNE each quarter. The narrative is still spreading — leaving room for ongoing capital accumulation.

📊

Mixed cohorts — 36% veterans, 31% new entrants

■ 36% veterans ■ 33% 1-2yr ■ 31% new

Of 114 current holders: 41 (36%) held 2+ years, 38 held 1–2 years, 35 (31%) entered in the past year. Balanced distribution — some institutional memory, some recent momentum buyers.

✅

Strong quality — 24% AUM from major funds

24% from top-100 AUM funds

38 of 111 holders rank in the top 100 by AUM, accounting for 24% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

4.1

out of 10

Moderate Exit Risk

Exit risk score 4.1/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Metric	All 13F Filers (2026 Q2)	Prior (2026 Q1)	Change
Funds Holding	111	97	14.43%
13F Shares	17M	17M	1.94%
Total Value	$548M	$345M	58.97%
New Positions	23	18	+5
Increased Positions	39	45	-6
Closed Positions	8	15	-7
Reduced Positions	30	16	+14
Total Calls	2	3	-33.33%
Total Puts	1	2	-50.0%
PUT/CALL Ratio	0.5	0.67	Bullish

Metric

All 13F Filers (2026 Q2)

Prior (2026 Q1)

Change

Funds Holding

111

14.43%

13F Shares

17M

1.94%

Total Value

$548M

$345M

58.97%

New Positions

Increased Positions

-6

Closed Positions

-7

Reduced Positions

+14

Total Calls

-33.33%

Total Puts

-50.0%

PUT/CALL Ratio

0.5

0.67

Bullish

Institutional Holders (2026 Q2)

111 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in NGNE. Verified SEC 13F-HR filings.

QUARTER:

FILTER:All New Added To Reduced No Change | Overweight >5%

Top 25 NGNE holders by conviction (% of portfolio weight) — 2026 Q2 · Source: SEC Form 13F
#	Investor	% of Portfolio	Shares	Mkt Value
1	Samsara BioCapital, LLC	4.44%	1,717,127	$54.0M
2	Trails Edge Capital Partners, LP	3.57%	714,885	$22.5M
3	Redmile Group, LLC	2.98%	1,412,199	$44.4M
4	Casdin Capital, LLC	2.43%	1,545,361	$48.6M
5	Great Point Partners LLC	2.09%	352,180	$11.1M
6	EcoR1 Capital, LLC	1.94%	1,271,342	$40.0M
7	DAFNA Capital Management LLC	0.53%	89,032	$2.8M
8	ArrowMark Colorado Holdings LLC	0.45%	342,453	$10.8M
9	Rtw Investments, LP	0.37%	1,362,456	$42.8M
10	Rock Springs Capital Management LP	0.16%	106,750	$3.4M
11	Baker BROS. Advisors LP	0.16%	991,691	$31.2M
12	Seven Fleet Capital Management LP	0.11%	22,060	$694K
13	Virtus Investment Advisers, LLC	0.08%	11,244	$354K
14	Moore Capital Management, LP	0.07%	141,636	$4.5M
15	Balyasny Asset Management L.P.	0.03%	818,706	$25.7M
16	Driehaus Capital Management LLC	0.03%	143,528	$4.5M
17	Toronto Dominion Bank	0.02%	681,337	$21.4M
18	XTX Topco Ltd	0.02%	55,424	$1.7M
19	Pale Fire Capital SE	0.02%	9,460	$298K
20	Trexquant Investment LP	0.01%	73,762	$2.3M
21	Raiffeisen Bank International AG	0.01%	34,000	$1.1M
22	Blair William & Co/Il	0.01%	146,905	$4.6M
23	ADAR1 Capital Management, LLC	0.01%	7,800	$245K
24	Bridgeway Capital Management, LLC	0.01%	18,781	$591K
25	Jennison Associates LLC	0.01%	518,582	$16.3M

Investor	Ownership History	% of Portfolio	Prev %	Rank	Conviction	Avg Buy Price	13F Score™ 3Y / 7Y	Sell Timing	Shares	Mkt Value	Change	Change %	Source	Quarter	Filed

Frequently Asked Questions — Neurogene Inc (NGNE)

What does the Smart Money Trend signal show for NGNE?

Buying streak — 4 quarters in a row: For 4 consecutive quarters, more hedge funds added NGNE than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for NGNE?

More buyers than sellers — 62% buying: Last quarter: 63 funds were net buyers (23 opened a brand new position + 40 added to an existing one). Only 39 were sellers (31 trimmed + 8 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for NGNE holders?

Strong quality — 24% AUM from major funds: 38 of 111 holders rank in the top 100 by AUM, accounting for 24% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held NGNE?

Mixed — 36% long-term, 29% new: Of the 112 current holders: 40 (36%) held >2 years, 40 held 1–2 years, and 32 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.

Is it too late to buy Neurogene Inc (NGNE) following the 2026 Q2 hedge fund 13F filings?

As of today, NGNE has moved +6.9% since the 2026 Q2 13F filing date (August 14, 2026), compared to +4.3% for the XLV sector ETF — an outperformance of +2.6%. Since the quarter end (June 30, 2026), NGNE has gained +22.8% vs +10.1% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Market Cap	--
Enterprise Value	--
Trailing P/E	--
Forward P/E	--
PEG Ratio (5yr expected)	--
Price/Sales (ttm)	--
Price/Book (mrq)	--
Enterprise Value/Revenue	--
Enterprise Value/EBITDA	--
Beta (5Y Monthly)	--
Short Ratio (Days to Cover)	--
Short % of Float	--

Profit Margin	--
Return on Assets (ttm)	--
Return on Equity (ttm)	--

Revenue (ttm)	--
Net Income Avi to Common (ttm)	--
Diluted EPS (ttm)	--
Total Cash (mrq)	--
Total Debt/Equity (mrq)	--
Levered Free Cash Flow (ttm)	--

Neurogene Inc (NGNE)

Smart Money Signals — NGNE

Buying streak — 4 quarters in a row

At the ownership peak (100% of max)

Fast accumulation — +35% more funds vs a year ago

More buyers than sellers — 62% buying

Steady new buyers — ~23 new funds per quarter

Mixed — 36% long-term, 29% new

Value +59% but shares only +2% — price-driven

Growing discovery — still being found

Mixed cohorts — 36% veterans, 31% new entrants

Strong quality — 24% AUM from major funds

Institutional Sentiment Summary — NGNE

Hedge Fund Ownership: NGNE

Market Analysis: NGNE

Analyst Price Targets

Analyst Recommendations

Stock Performance

Company Profile: NGNE

Is It Too Late to Buy Neurogene Inc (NGNE) Based on Hedge Fund 13F Filings?

Hedge Fund Positioning: NGNE

Statistics: NGNE

Valuation Measures Data as of: --

Financial Highlights

Institutional Holders (2026 Q2)

Frequently Asked Questions — Neurogene Inc (NGNE)

Welcome to 13Foresight!